Evidence map›Paper›PMID 20964819›Full record

ArticleBMC genomics2010

A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteins.

Krzysztof Pawłowski, Anna Muszewska, Anna Lenart, Teresa Szczepińska, Adam Godzik, Marcin Grynberg

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Krzysztof PawłowskiInstitute of Biochemistry and Biophysics, PAS, Pawińskiego 5A, 02-106 Warsaw, Poland. k.pawlowski@nencki.gov.pl
Anna Muszewska
Anna Lenart
Teresa Szczepińska
Adam Godzik
Marcin Grynberg
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLSanford Burnham Prebys Medical Discovery Institute · USWarsaw University of Life Sciences · PL

Funding

Development of a comprehensive system for distant homology analysisR01GM087218 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI GODZIK, ADAM · 2009 to 2010
$955k
NIGMS NIH HHS R01 GM087218
6 · The paper itself

Abstract

backgroundPeroxide turnover and signalling are involved in many biological phenomena relevant to human diseases. Yet, all the players and mechanisms involved in peroxide perception are not known. Elucidating very remote evolutionary relationships between proteins is an approach that allows the discovery of novel protein functions. Here, we start with three human proteins, SRPX, SRPX2 and CCDC80, involved in tumor suppression and progression, which possess a conserved region of similarity. Structure and function prediction allowed the definition of P-DUDES, a phylogenetically widespread, possibly ancient protein structural domain, common to vertebrates and many bacterial species.

resultsWe show, using bioinformatics approaches, that the P-DUDES domain, surprisingly, adopts the thioredoxin-like (Thx-like) fold. A tentative, more detailed prediction of function is made, namely, that of a 2-Cys peroxiredoxin. Incidentally, consistent overexpression of all three human P-DUDES genes in two public glioblastoma microarray gene expression datasets was discovered. This finding is discussed in the context of the tumor suppressor role that has been ascribed to P-DUDES proteins in several studies. Majority of non-redundant P-DUDES proteins are found in marine metagenome, and among the bacterial species possessing this domain a trend for a higher proportion of aquatic species is observed.

conclusionsThe new protein structural domain, now with a broad enzymatic function predicted, may become a drug target once its detailed molecular mechanism of action is understood in detail.

Indexed as

Disease ProgressionAmino Acid MotifsAmino Acid SequenceBacterial ProteinsConserved SequenceGlioblastomaHumansMembrane ProteinsModels, MolecularMolecular Sequence DataPeroxiredoxinsPhylogenyProtein MultimerizationProtein Structure, TertiarySequence AlignmentTumor Suppressor ProteinsBacterial ProteinsMembrane ProteinsPeroxiredoxinsSRPX protein, humanTumor Suppressor Proteins

Identifiers

PMID20964819
PMCPMC3091736
OpenAlexW2116044074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.